Ritika Jankar/LinkedIn
May 18, 2026, 13:10
Ritika Jankar: Hemophilia Market Size to Reach USD 23.46 Billion by 2035
Ritika Jankar, Search Engine Optimization Executive at Precedence Research, shared on LinkedIn:
”Hemophilia Market Size to Reach USD 23.46 Billion by 2035
According to industry insights, the global hemophilia market size was valued at USD 12.50 billion in 2025 and is projected to reach approximately USD 23.46 billion by 2035, expanding at a CAGR of 6.50% during the forecast period.
Key Growth Factors Driving the Hemophilia Market
- Rising diagnosis rates and awareness of bleeding disorders
- Increasing adoption of prophylactic therapies
- Rapid advancements in gene and cell therapy
- Growing development of recombinant coagulation factors
- Expanding healthcare infrastructure in emerging economies
- Technological advancements in AI-driven diagnostics and patient monitoring
- Strong investments in rare disease research and innovation
Emerging Market Opportunities
- Next-generation gene therapy development
- Personalized medicine and precision healthcare
- AI-powered treatment planning and predictive analytics
- Expansion of homecare and self-administration therapies
- Increasing penetration of advanced therapies in Asia Pacific
- Development of long-acting and non-factor replacement therapies
Explore detailed market insights.”

Stay updated with Hemostasis Today.
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation
-
Jul 13, 2026, 22:33ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026